Novel Drug Approvals in 2020 and 2021
Novel treatment options are available for patients that may substantially improve the public health. From drugs that treat migraine headaches to drugs that treat COVID-19, the new drugs introduced to the market will likely have a profound impact on a wide range of diseases. To be relevant practitioners, pharmacists need to have a thorough understanding of the newly approved medications. The purpose of this knowledge-based activity is to educate pharmacists on some of the most recently approved drugs. More specifically, there will be information provided on the effectiveness, safety, and handling of new drug approvals in the inpatient and outpatient settings.
At the completion of the activity, the participant will be able to:
List the top novel drugs approved by the Food and Drug Administration (FDA) in 2020 and 2021
List the clinical indications and common adverse effect of the top novel drugs
Describe the approved dosing guidelines and recommended dosage adjustments for the drugs reviewed
Join Zoom Meeting
Meeting ID: 994 5046 1320
One tap mobile
+16468769923,,99450461320#,,,,*544028# US (New York)
+13017158592,,99450461320#,,,,*544028# US (Washington DC)
Dial by your location
+1 646 876 9923 US (New York)
+1 301 715 8592 US (Washington DC)
+1 312 626 6799 US (Chicago)
+1 669 900 6833 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)
Meeting ID: 994 5046 1320
Eric Ocheretyaner, PharmD, BCPS, BCIDP
Assistant Professor of Pharmacy Practice
Infectious Diseases Clinical Pharmacist
The Arnold & Marie Schwartz College of Pharmacy and Health Sciences
Dr. Eric Ocheretyaner earned his Doctorate degree in pharmacy at The Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University in Brooklyn, NY. He completed his PGY2 in Infectious Diseases and PGY1 Pharmacy Practice Residency at SUNY Downstate Medical Center, Brooklyn, NY. Dr. Ocheretyaner is currently an Assistant Professor of Pharmacy Practice and practices as an Infectious Diseases clinical pharmacist at Staten Island University Hospital Northwell Health. His research interests include HIV and multi-drug resistant bacterial infections.
Mohamad Sow, PharmD
PGY-1 Pharmacy Resident
Staten Island University Hospital
Mohamad Sow earned his Doctor of Pharmacy degree from Touro College of Pharmacy in Harlem, New York in May 2020. Mohamad is one of the current PGY1 Pharmacy Residents at Staten Island University Hospital (SIUH), affiliated with Northwell Health. Mohamad finds his passion in oncology and infectious diseases. He enjoys teaching and is passionate about mentoring students. Mohamad will be receiving his Teaching Certificate from Long Island University (LIU) this spring.
No conflicts of interest exist with these presenters
ACPE UAN # 0042-0000-21-025-L01-P
- 1.50 ACPEThe Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.